Bupivacaine added to schedule of prohibited drugs

The Canadian Pari-Mutuel Agency (CPMA) has officially added bupivacaine to paragraph 1(d) of the Schedule to the Pari-Mutuel Betting Supervision Regulations. This drug was previously prohibited under paragraph 1(b) as a human drug.

This change is due to the recent approval of a veterinary product containing bupivacaine by Health Canada.

Bupivacaine is a local anesthetic similar to lidocaine and mepivacaine and is used to block pain.

To receive Canadian Pari-Mutuel Agency email notifications or to unsubscribe from the distribution list send an email to aafc.cpmawebacpm.aac@agr.gc.ca.

From the Canadian Pari-Mutuel Agency